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OBJECTIVES The study evaluated the risk of cardiovascular mortality according to combined spontaneous
(non-treatment-related) changes in both systolic and diastolic blood pressure (BP).
BACKGROUND Long-term longitudinal changes in blood pressure may be a more accurate determinant of
cardiovascular risk since changes in systolic or diastolic blood pressure over a period of time
reflect the evolution of arterial and arteriolar alterations.
METHODS Two independent French male cohorts were studied: the IPC cohort (Investigations
Préventives et Cliniques) composed of 15,561 men aged 20 to 82 years who had had two visits
spaced four to 10 years apart, and the Paris Prospective Study composed of 6,246 men aged
42 to 53 years, examined annually for a period of four years. None of the subjects were taking
antihypertensive medication. Annual changes in BP were estimated, and subjects were
divided into groups according to the increase, lack of change, or decrease of systolic or
diastolic BP. Nine groups were formed by combining the changes of systolic and diastolic BP.
Cardiovascular mortality was assessed for a mean period of 13.5 years for the IPC Study and
17 years for the Paris Prospective Study.
RESULTS In both cohorts, after adjustment for age and major risk factors, the group with an increase
in systolic and a decrease in diastolic BP presented the highest relative risk of cardiovascular
mortality compared to the group with no changes in either systolic or diastolic BP (relative
risk: 2.07 [1.05 to 4.06] in the IPC Study and 2.16 [1.16 to 4.01] in the Paris Prospective
Study).
CONCLUSIONS Assessment of spontaneous changes of BP over a long period of time can contribute to the
evaluation of cardiovascular risk. Subjects whose systolic BP increased while their diastolic BP
decreased had the highest cardiovascular risk independently of absolute values of BP or other
risk factors. (J Am Coll Cardiol 2000;35:673–80) © 2000 by the American College of
Cardiology
In various epidemiological studies a strong positive relation-
ship between cardiovascular disease and blood pressure (BP)
has been reported (1,2). It has been shown that both systolic
and diastolic BP are associated with cardiovascular disease
risk. This is to be expected as these two parameters are
closely correlated in most subjects. In 1980, the Framing-
ham Study (3) showed that high systolic BP was the best
predictor of both all-cause and cardiovascular mortality,
even among individuals with diastolic hypertension. This
study, and others as well, have shown that after adjustment
for systolic BP, the relationship between diastolic BP and
the risk of cardiovascular disease is either absent or negative,
especially in subjects over 45 years of age (3,4). This
observation suggests that diastolic BP levels, which are the
gold standard criterion in most clinical trials, may not be
specific or sensitive enough, and may at times even be
misleading, in determining cardiovascular disease risk. We
believe that this is due to the fact that diastolic BP levels
may not reflect the importance of arterial and arteriolar
alterations, which are associated with cardiovascular mor-
bidity and mortality.
Thus, although high systolic BP usually reflects an
elevation in total peripheral resistance and/or large artery
stiffness, diastolic BP levels are influenced by arterial or
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arteriolar alterations in opposite ways: an increase in peripheral
vascular resistance leads to an elevation in diastolic BP, whereas
stiffening of large arteries can induce a decrease in diastolic BP
(5,6). Therefore, normal levels of diastolic BP are influenced by
the combination of these two vascular alterations, which are
both independent risk factors of cardiovascular disease, espe-
cially coronary artery disease (7,8). This leads to the conclusion
that levels of diastolic BP may not necessarily reflect cardio-
vascular risk, especially in older subjects among whom arterial
stiffness is more frequent.
Long-term longitudinal changes in BP may be a more
accurate determinant of BP-related risk; this is because
changes in systolic BP or diastolic BP over a period of time
reflect the evolution of arterial and arteriolar alterations.
Witteman et al. (9) showed that, in women, a decrease in
diastolic BP during a nine-year follow-up was associated
with a progression of atherosclerotic lesions of the aorta.
The investigators suggested that the decrease of diastolic BP
could be a marker of atherosclerosis.
To our knowledge, there are no epidemiological data
showing the effect of spontaneous (non-treatment-related)
changes of systolic and diastolic BP over an extended period
of time, on cardiovascular mortality. The present analysis
was performed in two independent French male cohorts: the
IPC (Investigations Préventives et Cliniques) cohort, con-
sisting of 15,561 males who had had two visits spaced four
to 10 years apart at the “IPC” Centre, and the Paris
Prospective Study I, consisting of 6,246 men who had had
an annual medical exam over a four-year period. The
associations between combined changes in systolic BP and
diastolic BP over this period were studied, and subsequent
cardiovascular mortality was also assessed (a mean period of
13.5 years for the IPC Study and 17 years for the Paris
Prospective Study, beginning after the last visit).
METHODS
Population and Mortality Data
The IPC Study. The French national health care system
(Securite´ Sociale–CNAM) provides all working and retired
persons and their families with a free medical examination.
The IPC Center is one of the largest medical centers of this
kind in France, having carried out approximately 20,000
examinations annually since 1970 for people living in the
Paris area. Approximately 20% of those examined voluntar-
ily come back four to 10 years later for another checkup (a
minimum of four years between two visits is required to
qualify for a free examination). In the IPC database, 17,439
male subjects had the first examination between 1973 and
1987 and a second one between 1978 and 1991. When
subjects had more than two examinations, the first two were
used for the analysis. Subjects with antihypertensive treat-
ment at the time of the first or second visit, or those who
had taken antihypertensive medication between the two
visits, were excluded from the analysis (n 5 1,568). Three
hundred and ten additional subjects were eliminated be-
cause of missing clinical or mortality data. All other male
subjects were included in this analysis. Thus, in the present
study, data describe a population composed of 15,561 men
aged 20 to 82 years (mean 42 6 10 years).
Supine BP was measured in the right arm by a nurse, using
a manual sphygmomanometer. After a 10-min rest period, BP
was measured three times and the mean of the last two
measurements was calculated. Family medical history (diabe-
tes, hypertension, cardiovascular disease and sudden death
before 60 years), personal drug regimen and tobacco consump-
tion were assessed using a self-administered questionnaire.
Blood samples for biological tests were drawn under fasting
conditions.
The follow-up study period ended in December 1996.
The minimum follow-up period after the second visit was 5
years, the maximum was 17 years, and the mean follow-up
period was 13.5 years. Deceased subjects were identified
from the mortality records at the Institut National de
Statistiques et d’Etudes Economiques (INSEE). A patient
from our cohort was classified as deceased when he had the
same first name, last name, gender and date of birth as a
person recorded in the INSEE mortality records during the
period of the follow-up. By using this matching procedure,
the identification error was less than 1%. Only subjects
meeting all four of these criteria were classified as deceased.
All other subjects were considered to be alive at the end of
the follow-up period. Following this procedure, 874 subjects
from our cohort were classified as having died during the
follow-up period. Causes of mortality were taken from the
death certificates. These data were provided by the Depart-
ment of Mortality (SC 8) at the National Institute of Health
and Medical Research (INSERM). Causes of death were
codified according to the International Classification of
Disease (8th revision until 1978, 9th revision thereafter).
Paris Prospective Study I. Details pertaining to recruit-
ment, design, and procedures of the Paris Prospective Study
I have been described elsewhere (10). Briefly, the first
examination (baseline) for 7,746 French policemen aged 43
to 52 years was carried out between 1967 and 1972. Subjects
Abbreviations and Acronyms
BMI 5 body mass index
BP 5 blood pressure
Dia1 5 increase in diastolic blood pressure
Dia2 5 decrease in diastolic blood pressure
Dia7 5 no change in diastolic blood pressure
INSEE 5 Institute National de Statistiques et
d’Etudes Economiques
INSERM 5 National Institute of Health and Medical
Research
IPC 5 Investigations Pre´ventives et Cliniques
Sys1 5 increase in systolic blood pressure
Sys2 5 decrease in systolic blood pressure
Sys7 5 no change in systolic blood pressure
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had a physical examination, provided blood samples for
laboratory tests and answered questionnaires administered
by trained interviewers, regarding sociodemographic factors,
medical history and smoking habits. Each year following the
baseline examination and up to four years after, all subjects
were invited to undergo a similar follow-up examination.
The number of participants per cohort who had one, two,
three, four, or five examinations was 614, 604, 601, 1,671
and 4,456, respectively. During each examination, BP was
measured in the sitting position after at least a 5-min rest,
and the mean of two measurements was used for the
analysis. Through inquiries made to hospitals, family phy-
sicians and medical services at work, men were followed up
until January 1, 1994. Date and place of death were also
noted, and the medical causes of death were obtained from
death certificates from INSERM, in the same manner as for
the IPC cohort. Of the 7,332 subjects who had at least two
examinations, the vital status after an average follow-up of
17 years after the last examination was obtained for 6,892
subjects (94%). In the present study, we included all subjects
of this cohort who did not receive antihypertensive treat-
ment and for whom complete clinical and mortality data
were obtained.
BP Change Calculation
The IPC Study. Individual annual changes in systolic BP
and in diastolic BP were calculated as the difference between
the second and the baseline value, divided by the time
between the two visits. Mean time delay between the first
and the second visit was 6.1 6 1.7 years. Blood pressure
increased significantly over time in the entire population
(0.2 6 2.5 and 0.2 6 2.0 mm Hg per year for systolic BP
and diastolic BP, respectively, p , 0.001 for each). Annual
changes in systolic BP and in diastolic BP were regressed on
baseline values, and residuals were divided into tertiles. For
systolic BP, the lowest tertile (i.e., a decrease [2] in systolic
BP) included men whose systolic BP fell by .5.4 mm Hg
per five years; the highest tertile (i.e., an increase [1] in
systolic BP) included those whose systolic BP increased by
.3 mm Hg per five years; and the intermediate tertile was
considered as a lack of change (7) in systolic BP. The
respective cutoff points for tertiles for diastolic BP changes
were 22 mm Hg and 13 mm Hg per five years. Nine
groups of subjects were formed by combining the changes of
systolic BP and diastolic BP between the two visits.
Paris Prospective Study I. Changes in systolic BP and in
diastolic BP from the first through the last (fifth or less)
examination were estimated using a within-person linear
regression method. Systolic BP and diastolic BP were
regressed onto calendar time. On the average, systolic BP
increased and diastolic BP significantly decreased over time
in the entire population (0.2 6 5.2 mm Hg per year; p 5
0.004 and 20.5 6 4.0 mm Hg per year; p , 0.001,
respectively). The resulting annual average systolic BP and
diastolic BP changes (regression slopes) were then regressed
on baseline values, and residuals were divided into tertiles.
The cutoff points for tertiles were 210.6 and 15.9 mm Hg
per five years for changes in systolic BP and 26.7 and
15.4 mm Hg per five years for changes in diastolic BP. The
final sample consisted of 6,246 subjects who were not
treated for hypertension and for whom complete data were
available.
Statistical analysis. Data from each cohort were analyzed
separately. Death rates for the different causes of mortality,
according to the systolic BP/diastolic BP-change groups,
were compared using a x2 test, and differences in survival
probability were tested using log-rank test. A Cox multi-
variate analysis evaluated risks of cardiovascular mortality
adjusted for baseline age, total cholesterol, tobacco con-
sumption, diabetes and body mass index (BMI). Because
initial BP levels were taken into account in the calculation of
BP changes and the formation of the different groups,
adjustment for BP was not necessary. The group Sys7Dia7
(lack of change in both systolic BP and diastolic BP between
the two visits) was considered as the reference group. All
statistical analyses were performed using SAS software.
RESULTS
Table 1 shows the primary patient characteristics of the two
cohorts, recorded during the first visit. Subjects from the
Paris Prospective Study were older by five years, presented
higher values of systolic BP, BMI and serum triglycerides,
and the percentage of tobacco consumption was very high.
There were 1,674 deaths (26.8%) among the study partici-
pants during the 17-year follow-up period, 475 (28.4% of
deaths) of which were from cardiovascular disease. In the
IPC cohort, 874 (5.6%) subjects died. Among them, 207
(23.6% of deaths) died from cardiovascular causes.
Analysis by Subgroups According to the Changes in BP
The IPC Study. Table 2 shows the nine groups of subjects
according to the changes in systolic and diastolic BP. No
Table 1. Patient Characteristics for the Two French Cohorts
Recorded During the First Visit and Number of Cardiovascular
Deaths During Follow-up
IPC Study
Paris Prospective
Study I
Number of subjects 15,561 6,246
Number of CV deaths 207 475
Age (yrs) 41.9 (9.8) 47.1 (2.0)
BMI (kg/m2) 24.4 (2.8) 25.8 (3.2)
Systolic BP (mm Hg) 132.6 (13.4) 137.9 (19.1)
Diastolic BP (mm Hg) 81.6 (9.9) 81.9 (14.6)
Cholesterol (mmol/liter) 5.55 (0.98) 5.70 (1.1)
Triglycerides (mmol/liter) 1.09 (0.86) 1.53 (1.24)
Glycemia (mmol/liter) 5.70 (0.81) 5.69 (0.85)
Current smokers (%) 27.9 73.4
Ex-smokers (%) 40.3 10.5
675JACC Vol. 35, No. 3, 2000 Benetos et al.
March 1, 2000:673–80 Blood Pressure Changes and Cardiac Risk
large differences among the groups were found for age and
baseline BP. Mean values for total cholesterol, triglycerides,
glycemia, percentage of smokers, and physical activity were not
statistically significant in the nine groups (data not shown).
Cardiovascular mortality rates according to the systolic
BP changes were 7.1 deaths per 10,000 person-years in the
Sys2 (decrease in systolic BP), 7.7 per 10,000 person-years
in the Sys7 (no change in systolic BP) and 15.5 per 10,000
person-years in the Sys1 (increase in systolic BP). Accord-
ing to the diastolic BP changes, mortality rates were 9.6, 6.8
and 13.7 deaths per 10,000 person-years, respectively.
According to the combined changes of both systolic BP
and diastolic BP, the analysis in all nine groups showed that
the Sys1Dia2 (increase in systolic and decrease in diastolic
BP) group presented the highest rates for total cardiovas-
cular mortality (24.4 deaths per 10,000 person-years) (Table
2). The Cox regression showed that after adjustment for age
alone or age and other risk factors, the Sys1Dia2 group was
the only group to present a significantly higher risk of
cardiovascular mortality compared to the reference group
(Sys7Dia7 [no change in systolic and no change in dia-
stolic BP]) (Table 3). Analyses performed separately (ac-
cording to the mean value of age,—that is, 42 years) showed
that the higher risk in the Sys1Dia2 group was observed in
both younger and older subjects. Change in pulse pressure
was also a significant determinant of cardiovascular mortal-
ity in this cohort. After adjustment for age and other risk
factors, the risk ratio related to a 10 mm Hg increase in
pulse pressure was 1.9 (1.0 to 3.5) (p , 0.05).
The study of the survival curves for cardiovascular mor-
tality clearly indicates that increased mortality in the
Sys1Dia2 group was not related to an early mortality. This
analysis showed that the increased mortality in the
Sys1Dia2 group, compared to the reference group
(Sys7Dia7), clearly appeared after the fourth year of the
follow-up period and persisted up to the end of follow-up
(p 5 0.012) (Fig. 1, upper panel). Figure 1 also shows that
in the groups with a decrease in diastolic BP, without an
increase in systolic BP, the survival curve was not different
from the reference group. Finally, in groups with an increase
in systolic BP and without a decrease in diastolic BP, the
survival curve showed intermediate values between the
reference group and the Sys1Dia2 group.
Paris Prospective Study I. The characteristics of subjects
according to the changes in systolic and diastolic BP are
shown in Table 4. Mean age and baseline BP values were
not significantly different among the nine groups. Cardio-
vascular mortality rates according to the systolic BP changes
were 39.9 per 10,000 person-years in the Sys2, 37.4 per
10,000 person-years in the Sys7, and 57.1 per 10,000
person-years in the Sys1. According to the diastolic BP
changes, these rates were 41.8, 38.5 and 53.5, respectively.
The analysis in nine groups according to the combined
changes of both systolic BP and diastolic BP showed that
the highest cardiovascular mortality rates were observed inTa
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the Sys1Dia2 group (65.4 deaths per 10,000 person-years,
Table 4).
The relative risks for death from cardiovascular disease
are shown in Table 3. The age-adjusted relative risk for
subjects in the Sys1Dia2 group, compared with those in
the Sys7Dia7 group, was 2.14 [95% CI 1.15–3.96]. Mul-
tivariate adjustment for baseline risk factor levels did not
alter these findings. These results were very similar to those
observed in the IPC Study (Table 3). As for the IPC cohort,
analyses performed according to the mean value of age (47
years) showed that a higher risk of cardiovascular mortality
in the Sys1Dia2 group was observed in both younger and
older subjects. Subjects in the Sys1Dia1 (increase in
systolic and increase in diastolic BP) group were also at
higher risk compared with those in the Sys7Dia7 group.
As also observed for the IPC study, change in pulse
pressure was a significant determinant of cardiovascular
mortality in this cohort. After adjustment for age and other
risk factors, the risk ratio (95% CI) related to a 10 mm Hg
increase in pulse pressure was 1.7 (1.4–2.1) (p , 0.001.).
The study of the survival curves for cardiovascular mor-
tality in the Paris Prospective Study indicated similar trends
to those observed in the IPC Study (Fig. 1, lower panel).
DISCUSSION
The main result of this analysis performed in two independent
French male cohorts is that an increase over an extended period
of time in systolic BP combined with a decrease in diastolic BP
is associated with higher cardiovascular risk, independently of
age, initial BP levels and other risk factors. In both cohorts, this
BP-evolution profile was associated with a twofold increase in
cardiovascular mortality compared to subjects without changes
in both systolic BP and diastolic BP, despite similar BP levels.
We suggest that the assessment of BP changes over an
extended period of time can contribute to better identifying
high-risk subjects.
Cardiovascular mortality according to systolic and dia-
stolic BP changes in two French cohorts. In the present
report, two independent French cohorts were analyzed sepa-
rately. As is shown in the Results section, subjects enrolled in
the Paris Prospective Study had much higher mortality rates
Figure 1. Survival probability curves for cardiovascular mortality in
different subgroups of subjects according to the changes in systolic
and diastolic blood pressure, in the IPC Study (upper panel) and
in the Paris Prospective Study I (lower panel). Reference group
(RG; Sys7Dia7) included men whose systolic blood pressure and
diastolic blood pressure did not change over time. The Sys1Dia2
group included men whose systolic blood pressure increased and
diastolic blood pressure decreased. Other Sys1 included those
whose systolic blood pressure increased, whereas diastolic blood
pressure did not change or else increased (groups Sys1Dia7 and
Sys1Dia1). Other Dia2 included those whose diastolic blood
pressure decreased, whereas systolic blood pressure did not change
or else decreased (groups Sys7Dia2 and Sys2Dia2). In both
cohorts the Sys1Dia2 group showed higher cardiovascular mor-
tality versus the RG (p , 0.05 in both cohorts). Other Dia2
groups showed similar cardiovascular mortality versus the RG,
whereas other Sys1 groups presented intermediate cardiovascular
mortality rates.
Table 3. Relative Risk and 95% CI for Cardiovascular Mortality in the Nine Groups
IPC Study Paris Prospective Study I
Age Adjusted
Multivariate
Adjusted* Age Adjusted
Multivariate
Adjusted*
Sys2Dia2 0.96 (0.54–1.71) 0.96 (0.55–1.71) 1.04 (0.74–1.46) 1.03 (0.73–1.44)
Sys2Dia7 0.89 (0.43–1.83) 0.91 (0.44–1.87) 0.92 (0.61–1.38) 0.93 (0.62–1.40)
Sys2Dia1 0.97 (0.33–2.86) 0.98 (0.33–2.89) 1.43 (0.72–2.75) 1.55 (0.86–2.84)
Sys7Dia2 1.28 (0.67–2.43) 1.28 (0.67–2.44) 1.06 (0.69–1.63) 1.06 (0.69–1.63)
Sys7Dia7 1.00 (Reference Group) 1.00 (Reference Group) 1.00 (Reference Group) 1.00 (Reference Group)
Sys7Dia1 1.07 (0.54–2.14) 1.05 (0.53–2.10) 1.27 (0.87–1.86) 1.23 (0.84–1.80)
Sys1Dia2 2.07 (1.05–4.06)† 2.03 (1.03–3.99)† 2.14 (1.15–3.96)† 2.16 (1.16–4.01)†
Sys1Dia7 1.10 (0.56–2.18) 1.09 (0.55–2.15) 1.53 (1.03–2.26)† 1.46 (0.99–2.17)
Sys1Dia1 1.58 (0.95–2.63) 1.55 (0.93–2.58) 1.89 (1.40–2.54)‡ 1.77 (1.31–2.38)‡
*Adjusted for age, total cholesterol, tobacco consumption, diabetes and body mass index. †p , 0.05 and ‡p , 0.001 vs. reference group.
For abbreviations, see Table 1 and Methods section.
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compared to subjects in the IPC Study. The differences in
mortality can be explained in part by the fact that the subjects
from the Paris Prospective Study were older (mean age 47.1 vs.
41.9 years old) and that the follow-up period was longer (17 vs.
13.5 years). However, the main reason for this difference could
be that the prevalence of risk factors, especially tobacco
consumption, was much higher in the Paris Prospective Study
(see Table 1). This cohort was composed of policemen,
enrolled in the study between 1967 and 1972, and constituted
a population that was very exposed to risk factors. The fact
remains that despite these major differences, the following
noteworthy result was found in both cohorts: subjects with the
Sys1Dia2 profile presented a higher cardiovascular risk, a risk
that was twice as high as for the reference population
(Sys7Dia7).
Following the classification in tertiles according to the
progression of systolic BP and diastolic BP, the higher
cardiovascular death rates were observed in the Sys1 tertile.
This is not really surprising as this tertile had the higher
systolic BP levels during the second visit (i.e., at the
beginning of the follow-up period). Inside this tertile, one
would expect higher mortality rates in the subgroup, which
had the higher systolic BP and diastolic BP levels at the
time of the last visit. If we consider the subjects from the
IPC study, average BP values in the Sys1Dia2 group were
141/76 mm Hg during the last visit. In the Sys7Dia7 and
Sys1Dia1 groups the corresponding levels of BP were
141/82 mm Hg and 149/94 mm Hg, respectively. Based on
this logic, patients in the Sys1Dia1 group should pre-
sent the highest cardiovascular mortality compared to the
other groups. However, in the present study, the higher
cardiovascular mortality rates were observed among subjects
in the Sys1Dia2 group. This excess risk is independent of
absolute BP levels measured during single visits, and there-
fore can be determined only if the evolution of BP over an
extended period of time is taken into consideration.
Diastolic BP and cardiovascular risk.
Concerns regarding low levels of diastolic BP and cardio-
vascular morbidity and mortality have been published for
over 10 years (11,12). In 1987, Cruickshank et al. (13)
observed that the mortality rates from myocardial infarction
among treated patients with hypertension was lowest when
diastolic BP was 85 mm Hg. Above and below this value the
death rate was higher, suggesting that a J-shaped curve best
described the relationship between diastolic BP and myo-
cardial infarction mortality. This finding was restricted to
subjects with coronary heart disease. No such relationship
was apparent for systolic BP. The J-curve could be explained
by a lowered diastolic BP, which is not sufficient enough to
drive the diastolic coronary flow, especially in patients with
established coronary artery disease.
In addition, Cox et al. (14) pointed out that this rela-
tionship has been found in both normotensive individuals
and in hypertensive patients receiving placebos. In a detailed
review of the subject, Fletcher and Bulpitt (15) raised theTa
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question of whether or not low diastolic BP in patients with
isolated systolic hypertension predisposes that group to the
risk because of the increased myocardial needs due to
associated high systolic BP levels. The results of the present
analysis concur with this hypothesis, showing that a de-
crease in diastolic BP (non–drug-related in this case) was
harmful only when it was combined with an elevation in
systolic BP. On the contrary, when a decrease in diastolic
BP was accompanied with a concomitant decrease or lack of
change in systolic BP, cardiovascular risk did not increase
(Fig. 1).
Pulse pressure and cardiovascular risk. It has recently
been shown that increased pulse pressure was a strong
predictor of cardiovascular mortality, especially coronary
mortality, independently of mean BP levels (16–18). The
present results point out that the increase of systolic and
pulse pressure over time is probably due to an increase in
aortic stiffness and pulse-wave velocity and to accentuation
of the amplitude of the reflected pressure waves (5). We
believe that the present study helps clarify the role played by
arterial stiffening in cardiovascular complications. The
present results demonstrate the risk related to the increase in
pulse pressure due to both an increase in systolic BP and a
decrease in diastolic BP, which is the classic pattern of large
arteries stiffening. We can therefore suggest that other
causes leading to elevated pulse pressure, such as increased
stroke volume, may be considered less harmful. The study
emphasizes that the impact of systolic and pulse pressure is
not only observed in the elderly but also in a middle-aged
population sample.
Clinical applications. Therapeutic decision-making and
management in patients with mild to moderate hyperten-
sion are based on the evaluation of cardiovascular risk.
Clinicians therefore have sought more precise ways of
describing individual patient outlooks. One of the problems
when treating for hypertension is that very large numbers of
subjects have to be treated to prevent a small number of
cardiovascular complications (19). This suggests that the
standard criteria, systolic BP or diastolic BP, even if they are
generally correlated to cardiovascular risk, may not be
specific or sensitive enough to identify groups of subjects
that are at high risk owing to BP values. In the present
analysis we identified a subgroup of subjects, representing
approximately 3% of the total population, whose excess in
risk was independent of BP recorded during single visits,
age and other risk factors.
In the present study the same hypothesis was tested
separately in two independent French cohorts. Because the
Paris Prospective Study was composed only of men, only the
male population in the IPC cohort was analyzed. Results of
the present study may be of interest to clinicians for several
reasons. In the case of normal or slightly increased BP levels,
when treatment does not need to be proposed, long-term
follow-up of BP levels may help estimate an individual’s
cardiovascular risk and contribute to therapeutic decision
making. In subjects with high BP, for whom physicians
should propose a first treatment, comparison with older BP
readings when available could contribute to a better estima-
tion of cardiovascular risk.
In conclusion, assessment of spontaneous BP changes
over a long period of time may contribute to the evaluation
of cardiovascular risk. Subjects who present a combined
increase in systolic BP and a decrease in diastolic BP have
the highest risk, independently of absolute BP values and
other risk factors.
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